Sung-Wuk Kim
Fondatore presso ImmunoMet Therapeutics, Inc.
Patrimonio netto: 38 M $ in data 30/04/2024
Profilo
Sung-Wuk Kim is the founder of ImmunoMet Therapeutics, Inc. which was founded in 2015.
He currently holds the title of Chairman at ImmunoMet Therapeutics, Inc. Dr. Kim is also currently working as the Director at Korean Drug Research Association.
In the past, he held the position of President, Chief Executive Officer & Director at HANALL BIOPHARMA Co., Ltd.
from 2011 to 2014.
Dr. Kim also served as the Chief Executive Officer at Health Prime International LLC and as a Director at Bridge Biotherapeutics, Inc. Dr. Kim completed his undergraduate degree at Yonsei University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 30/09/2023 | 1 469 702 ( 2.81% ) | 38 M $ | 30/04/2024 |
Posizioni attive di Sung-Wuk Kim
| Società | Posizione | Inizio |
|---|---|---|
| Korean Drug Research Association | Direttore/Membro del Consiglio | - |
ImmunoMet Therapeutics, Inc.
 ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImmunoMet Therapeutics, Inc. operates as a development-stage biopharmaceutical company that develops and commercializes novel oncology products. It offers novel technology that designed to disrupt cancer cell growth and enhance anti-cancer immunity. The company was founded in July 2015 and is headquartered in Houston, TX. | Fondatore | 01/11/2017 |
Precedenti posizioni note di Sung-Wuk Kim
| Società | Posizione | Fine |
|---|---|---|
Health Prime International LLC
 Health Prime International LLC Miscellaneous Commercial ServicesCommercial Services Health Prime International LLC engages in the supply of outsourced medical billing services. It offers PrimeEHR, PrimeQuality, PrimeTranscription, PrimeContact, PrimeConsult, PrimeSmartCharge, and PrimeMarketing. The company was founded by Vinod K. Shah in 2004 and is headquartered in National Harbor, MD. | Amministratore Delegato | - |
| BRIDGE BIOTHERAPEUTICS, INC. | Direttore/Membro del Consiglio | - |
| HANALL BIOPHARMA CO., LTD. | Amministratore Delegato | - |
Formazione di Sung-Wuk Kim
| Yonsei University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| HANALL BIOPHARMA CO., LTD. | Health Technology |
| BRIDGE BIOTHERAPEUTICS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
| Korean Drug Research Association | |
Health Prime International LLC
Health Prime International LLC Miscellaneous Commercial ServicesCommercial Services Health Prime International LLC engages in the supply of outsourced medical billing services. It offers PrimeEHR, PrimeQuality, PrimeTranscription, PrimeContact, PrimeConsult, PrimeSmartCharge, and PrimeMarketing. The company was founded by Vinod K. Shah in 2004 and is headquartered in National Harbor, MD. | Commercial Services |
ImmunoMet Therapeutics, Inc.
ImmunoMet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImmunoMet Therapeutics, Inc. operates as a development-stage biopharmaceutical company that develops and commercializes novel oncology products. It offers novel technology that designed to disrupt cancer cell growth and enhance anti-cancer immunity. The company was founded in July 2015 and is headquartered in Houston, TX. | Health Technology |
- Borsa valori
- Insiders
- Sung-Wuk Kim
